Quantcast

Latest UCB Stories

2010-04-14 07:30:00

ATLANTA, April 14 /PRNewswire/ -- Evidence of Neupro® (Rotigotine Transdermal System) improving motor as well as non-motor symptoms of Parkinson's disease was presented at the 62nd American Academy of Neurology annual meeting in Toronto, Canada. "The new data reported this week showed that treatment with rotigotine controlled early morning motor function and improved non-motor symptoms, as judged by the validated non-motor scale, in patients with Parkinson's disease...

2010-04-09 08:16:00

ATLANTA, April 9 /PRNewswire/ -- The antiepileptic drug (AED) Vimpat® (lacosamide) (C-V) will be the subject of numerous studies and analyses at the 62nd annual American Academy of Neurology (AAN) meeting, taking place at the Metro Toronto Convention Centre in Toronto from April 10-17. To view the multimedia assets associated with this release, please click: http://www.prnewswire.com/mnr/vimpat/34012/ "The breadth and depth of Vimpat data being presented at AAN...

2010-04-08 07:30:00

ATLANTA, April 8 /PRNewswire/ -- Extensive new data on rotigotine will be presented at the 62nd American Academy of Neurology annual meeting in Toronto, Canada between April 10th and 17th, 2010. At a series of oral and poster presentations, leading international investigators will report the latest data on rotigotine in all stages of Parkinson's disease and in moderate to severe Restless Legs Syndrome (RLS). Oral presentations SP710 (5 year) Long-term Safety and Efficacy of Rotigotine...

2010-03-05 11:03:00

ATLANTA, March 5 /PRNewswire/ -- Applications are being accepted until March 19, 2010 for the UCB Rheumatoid Arthritis Family Scholarship. These scholarships are for rheumatoid arthritis patients or their immediate family members. Winners are awarded up to $10,000 to continue their studies at an accredited institution of higher education in the U.S. Requirements and an application can be found at http://www.reachbeyondra.com/scholarship. UCB awards more than 100 scholarships each year to...

2010-01-28 07:02:00

DALLAS, January 28 /PRNewswire/ -- Now in its 9th year, the ePharma Summit (http://www.epharmasummit.com), to be held this year at the Hyatt Regency at Penn's Landing, Philadelphia, PA ,continues to be the most innovative digital marketing event for the pharmaceutical sector. Year after year, hundreds of marketing professionals from leading pharmaceutical companies attend ePharma Summit for incomparable access to insider information, to optimize their brand strategy and perfect consumer...

2010-01-12 12:11:00

February 25-26 Forum to Bring Together Innovators, Clinicians and Investors MIDDLEBURG, Va., Jan. 12 /PRNewswire-USNewswire/ -- The Epilepsy Therapy Project (ETP), a non-profit organization dedicated to advancing new therapies for people living with epilepsy, announces the Epilepsy Pipeline Update 2010 conference, an in-depth, 2-day forum to be held February 25-26, 2010, at the Hyatt Embarcadero Hotel in San Francisco. The conference will feature a line up of leading innovators, clinical...

2010-01-12 07:00:00

WALTHAM, Mass., Jan. 12 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Boehringer Ingelheim's extended-release formulation of pramipexole (pramipexole ER), which launched late last year in Europe and is expected to launch this year in the United States, will garner peak year sales of $250 to $500 million in the world's major pharmaceutical markets. The Pharmacor finding from the topic...

2009-12-14 01:00:00

BRUSSELS, December 14 /PRNewswire-FirstCall/ -- - Results From a Survey Conducted by UCB Assessing the Lifestyles of Women With Rheumatoid Arthritis in Seven Major Industrialized Countries - A third of women living with rheumatoid arthritis say their disease impacts their enjoyment of the festive season - Women living with rheumatoid arthritis find shopping for gifts, preparing holiday food, writing cards and wrapping presents most difficult to do -...

2009-12-07 05:40:00

ATLANTA, Dec. 7 /PRNewswire-FirstCall/ -- UCB today announced new findings on its antiepileptic drug (AED) Vimpat® that offer additional clinical evidence supporting the use of this AED as adjunctive therapy in adult patients with partial-onset seizures. Results of presented research demonstrate sustained efficacy in adult patients taking Vimpat® for up to three years, and a consistent long-term tolerability profile. A separate study reports that...

2009-11-03 08:05:00

ATLANTA, Nov. 3 /PRNewswire/ -- UCB, an active participant in the epilepsy community for more than a decade, is proudly launching a variety of patient-centered initiatives in honor of Epilepsy Awareness Month in November. These programs are the culmination of years of experience in the epilepsy community and seek to empower patients, improve epilepsy care, and raise awareness about the condition. "At UCB, our goal has always been to make a meaningful and lasting difference in the epilepsy...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related